OPT - Timothy E. Morris is the new finance chief of Opthea
- Opthea ( NASDAQ: OPT ) appoints veteran pharmaceutical executive Timothy E. Morris as CFO, effective 24 October 2022.
- Most recently he served as COO/CFO of Humanigen.
- Mr. Morris’ accomplishments include raising over $2.5B in equity and convertible securities for seven companies and the completion of over 95 transactions.
- “We are delighted to welcome Mr. Morris, whose more than 25 years CFO experience with public biotechnology companies will benefit Opthea as we prepare for Phase 3 trial results and advance pre-commercial activities,” commented Dr. Megan Baldwin, Chief Executive Officer and Managing Director of Opthea.
For further details see:
Timothy E. Morris is the new finance chief of Opthea